Healthcare New Highs: HCA Holdings Inc. (NYSE:HCA), Allergan, Inc. (NYSE:AGN), LifePoint Hospitals (NASDAQ:LPNT), POZEN Inc. (NASDAQ:POZN)

HCA Holdings Inc. (NYSE:HCA), the largest for-profit U.S. hospital chain, is weighing an offer for Australian health-care provider Health scope Ltd. said people familiar with the matter. HCA Holdings Inc. (NYSE:HCA) shares after opening at $51.24 moved to $53.73 on last trade day and at the end of the day closed at $53.44. Company price to sales ratio in past twelve months was calculated as 0.69 and price to cash ratio as 57.28. HCA Holdings Inc. (NYSE:HCA) showed a positive weekly performance of 9.04%.

One of Allergan Inc. (NYSE:AGN) biggest shareholders is no fan of a $46 billion buyout backed by Pershing Square Capital Management. Allergan, Inc. (NYSE:AGN) shares advanced 0.92% in last trading session and ended the day on $168.15. AGN return on equity ratio is recorded as 14.70% and its return on assets is 8.80%. Allergan, Inc. (NYSE:AGN) yearly performance is 51.23%.

The gross profit margin for LifePoint Hospitals, Inc. (NASDAQ:LPNT) is rather low; currently it is at 20.69%. Regardless of LPNT’s low profit margin, it has managed to increase from the same period last year. Despite the mixed results of the gross profit margin, LPNT’s net profit margin of 3.73% compares favourably to the industry average. LifePoint Hospitals, Inc. (NASDAQ:LPNT) shares moved up 6.28% in last trading session and was closed at $56.87, while trading in range of $54.18 – $57.13. LifePoint Hospitals, Inc. (NASDAQ:LPNT) year to date (YTD) performance is 7.63%.

POZEN Inc. (NASDAQ:POZN), a pharmaceutical company committed to transforming medicine that transforms lives, announced yesterday that their drug candidates PA8140/PA32540 (aspirin and omeprazole) delayed release tablets have received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA). A CRL is issued by the FDA when the review of the file is completed and questions remain that preclude the approval of the new drug application (NDA) in its current form. POZEN Inc. (NASDAQ:POZN) weekly performance is 4.94%. On last trading day company shares ended up $9.13. POZEN Inc. (NASDAQ:POZN) distance from 50-day simple moving average (SMA50) is 9.41%. Analysts mean target price for the company is $9.00.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *